MX2014013101A - Solucion de gemcitabina lista para infundir. - Google Patents

Solucion de gemcitabina lista para infundir.

Info

Publication number
MX2014013101A
MX2014013101A MX2014013101A MX2014013101A MX2014013101A MX 2014013101 A MX2014013101 A MX 2014013101A MX 2014013101 A MX2014013101 A MX 2014013101A MX 2014013101 A MX2014013101 A MX 2014013101A MX 2014013101 A MX2014013101 A MX 2014013101A
Authority
MX
Mexico
Prior art keywords
infused
ready
gemcitabine
solution
large volume
Prior art date
Application number
MX2014013101A
Other languages
English (en)
Other versions
MX357935B (es
Inventor
Prashant Kane
Samarth Kumar
Alok B Namdeo
Subhas B Bhowmick
Kirti Ganorkar
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48325397&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014013101(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Publication of MX2014013101A publication Critical patent/MX2014013101A/es
Publication of MX357935B publication Critical patent/MX357935B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
    • B65D85/30—Containers, packaging elements or packages, specially adapted for particular articles or materials for articles particularly sensitive to damage by shock or pressure
    • B65D85/42—Containers, packaging elements or packages, specially adapted for particular articles or materials for articles particularly sensitive to damage by shock or pressure for ampoules; for lamp bulbs; for electronic valves or tubes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Una forma de dosificación de gemcitabina para infusión de gran volumen, que comprende una solución estable de gran volumen de gemcitabina o su sal farmacéuticamente aceptable en un vehículo acuoso lleno en un contenedor de infusión de gran volumen, en donde la solución está lista para ser infundida.
MX2014013101A 2012-04-27 2013-04-26 Solución de gemcitabina lista para infundir. MX357935B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1334MU2012 2012-04-27
PCT/IN2013/000281 WO2013171763A1 (en) 2012-04-27 2013-04-26 Ready to be infused gemcitabine solution

Publications (2)

Publication Number Publication Date
MX2014013101A true MX2014013101A (es) 2015-01-26
MX357935B MX357935B (es) 2018-07-31

Family

ID=48325397

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013101A MX357935B (es) 2012-04-27 2013-04-26 Solución de gemcitabina lista para infundir.

Country Status (16)

Country Link
US (1) US9241948B2 (es)
EP (1) EP2656848B2 (es)
JP (1) JP6159567B2 (es)
KR (1) KR101716215B1 (es)
CN (3) CN113577019A (es)
AU (1) AU2013261012B2 (es)
BR (1) BR112014026334B1 (es)
CA (1) CA2871061C (es)
ES (1) ES2537294T5 (es)
MX (1) MX357935B (es)
PL (1) PL2656848T5 (es)
PT (1) PT2656848E (es)
RU (1) RU2621144C2 (es)
SI (1) SI2656848T2 (es)
WO (1) WO2013171763A1 (es)
ZA (1) ZA201408502B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9064577B2 (en) 2012-12-06 2015-06-23 Micron Technology, Inc. Apparatuses and methods to control body potential in memory operations
JP2015000869A (ja) * 2013-06-18 2015-01-05 サムヤン バイオファーマシューティカルズ コーポレイション 有機溶媒無含有ゲムシタビン水溶液組成物
US10098813B2 (en) * 2014-09-03 2018-10-16 Sun Pharmaceutical Industries Limited Perfusion dosage form
JP6033931B2 (ja) * 2015-07-30 2016-11-30 サムヤン バイオファーマシューティカルズ コーポレイション 有機溶媒無含有ゲムシタビン水溶液組成物
US10114999B1 (en) 2016-12-02 2018-10-30 Koupon Media, Inc. Using dynamic occlusion to protect against capturing barcodes for fraudulent use on mobile devices
CN113365610A (zh) * 2018-10-04 2021-09-07 现代化制药公司 制备和递送比生群制剂的方法
WO2021028842A1 (en) * 2019-08-13 2021-02-18 Hetero Healthcare Limited A stable ready-to-use injectable composition of gemcitabine or its salt and methods for producing same

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135498A (en) * 1990-04-02 1992-08-04 Kam Robert J Controlled release infusion device
US20050031679A1 (en) * 1998-03-27 2005-02-10 Clemens Unger Method for producing liposomal formulations of active ingredients
US6969483B1 (en) * 2000-03-16 2005-11-29 Baxter International Inc. Autoclavable, non-adherent, heat sealable polymer blends for fabricating monolayer and multiple layered films
CN1181829C (zh) * 2000-11-03 2004-12-29 中国人民解放军军事医学科学院附属医院 吉西他滨溶液制剂
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
DE10323279A1 (de) * 2003-05-21 2004-12-16 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabin-Lösungen
US20060046964A1 (en) * 2004-09-02 2006-03-02 Andre Morneau Pharmaceutical formulations and methods
US20060089328A1 (en) * 2004-10-22 2006-04-27 Edgar Schridde Ready-to-use gemcitabine solutions
US20060089329A1 (en) 2004-10-22 2006-04-27 Edgar Schridde Ready-to-use gemcitabine solution concentrates
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
CN101088492B (zh) * 2006-06-12 2012-02-22 齐鲁制药(海南)有限公司 盐酸吉西他滨稳定的过饱和溶液及其制备方法
US8563022B2 (en) * 2006-10-11 2013-10-22 Board Of Regents Of The University Of Texas System Particles for cell targeting
CN101185654A (zh) 2007-12-11 2008-05-28 常州安孚立德药业技术有限公司 一种盐酸吉西他滨或吉西他滨组合物
CN102083428A (zh) * 2008-03-07 2011-06-01 顶标公司 采用长时间连续输液Belinostat进行治疗的方法
WO2011000811A2 (en) 2009-06-30 2011-01-06 Novartis Ag Organic compounds
JP5563528B2 (ja) * 2010-06-29 2014-07-30 高田製薬株式会社 ニコチン酸アミドを含有するゲムシタビン凍結乾燥製剤
JP2012017308A (ja) 2010-07-09 2012-01-26 Nipro Corp ゲムシタビン水溶液製剤

Also Published As

Publication number Publication date
KR20150014438A (ko) 2015-02-06
ES2537294T5 (es) 2018-12-10
MX357935B (es) 2018-07-31
BR112014026334A2 (pt) 2017-06-27
CA2871061C (en) 2017-06-20
US20130288994A1 (en) 2013-10-31
ES2537294T3 (es) 2015-06-05
EP2656848A1 (en) 2013-10-30
CN113577019A (zh) 2021-11-02
RU2014147388A (ru) 2016-06-20
WO2013171763A1 (en) 2013-11-21
KR101716215B1 (ko) 2017-03-27
JP6159567B2 (ja) 2017-07-05
BR112014026334B1 (pt) 2022-04-12
SI2656848T1 (sl) 2015-07-31
PL2656848T3 (pl) 2015-10-30
US9241948B2 (en) 2016-01-26
CN104254319A (zh) 2014-12-31
JP2013231029A (ja) 2013-11-14
AU2013261012B2 (en) 2017-02-02
EP2656848B1 (en) 2015-04-08
CN109077995A (zh) 2018-12-25
CA2871061A1 (en) 2013-11-21
RU2621144C2 (ru) 2017-05-31
BR112014026334A8 (pt) 2021-06-15
ZA201408502B (en) 2015-11-25
EP2656848B2 (en) 2018-09-19
AU2013261012A1 (en) 2014-11-13
PT2656848E (pt) 2015-07-01
PL2656848T5 (pl) 2019-02-28
SI2656848T2 (sl) 2019-04-30

Similar Documents

Publication Publication Date Title
MX2014013101A (es) Solucion de gemcitabina lista para infundir.
IL296105B2 (en) A low volume pre-filled syringe is sterilized
IL241889B (en) Closure of a medicine container to mount on an open medicine container to create a medicine preparation device for use with a syringe without a syringe
PL2925272T3 (pl) Układ do przechowywania, wydawania i podawania leków
MY189913A (en) Preparation containing tetracyclic compound at high dose
EP2888959A4 (en) CAPSULE WITH INCLUDED LIQUID AND SMOKING ITEMS WITH THIS CAPSULE
EP2865400A4 (en) STORAGE CONTAINER FOR SPRAYING
EP2939662A4 (en) TEMOCOLOMIDE-CONTAINING PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY AND METHOD OF MANUFACTURING THEREOF
IN2014DN10985A (es)
SG10201803430SA (en) Stable formulation of insulin glulisine
ZA201407060B (en) Needle retractable-type safe self-destructing syringe
EP2887800A4 (en) CONTAINER FOR BLOOD CONSERVATION CONTAINING AN AQUEOUS COMPOSITION FOR THE PRESERVATION OF RED GLOBLES
HK1210589A1 (en) Aqueous liquid medicine
AR093632A1 (es) Tratamiento de cafe soluble
TWD166457S (zh) 包裝用容器
HK1249848A1 (zh) 親脂性物質的水溶液，特別是藥物物質溶液
MX359688B (es) Dispositivo transdérmico que incluye micropartículas porosas.
WO2017094029A3 (en) Parenteral dosage form of diltiazem
RU2012123184A (ru) Способ управляемого снижения агрегационной активности тромбоцитов мексидолом в эксперименте
UA75631U (uk) Одноразова ємкість
Lublin Some problems of landuse for agricultural production (emfithevsis) and law of corregation of land for building purpoces (suprficij)
UA83813U (ru) Способ лечения нейросифилиса с мезенхимальными изменениями
TN2016000064A1 (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes
GR1007938B (el) Ποσιμα αντιπηκτικα φαρμακευτικα διαλυματα
UA83243U (uk) Спосіб введення активних речовин

Legal Events

Date Code Title Description
FG Grant or registration